Pages that link to "Q46436960"
Jump to navigation
Jump to search
The following pages link to Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study (Q46436960):
Displaying 9 items.
- Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis (Q24187362) (← links)
- Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects (Q28252888) (← links)
- Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis (Q34122907) (← links)
- A single-center study evaluating the effect of the controlled adverse environment (CAE(SM)) model on tear film stability (Q36410618) (← links)
- Validation and verification of the OPI 2.0 System (Q41839224) (← links)
- Effect of short‐term diphenhydramine administration on aqueous tear production in normal dogs (Q48217105) (← links)
- Clinical implications of mast cell involvement in allergic conjunctivitis (Q48361100) (← links)
- Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial (Q49261503) (← links)
- Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial (Q90451538) (← links)